Stop Talking and Start Testing New Clinical Trial Practices, ACRO Says
The drug industry needs to get over its risk-averse attitude on much talked about ideas to improve the clinical trials enterprise, and the FDA needs to provide sponsors with enforceable agreements that will give companies the confidence to branch out from the norm, Association of Clinical Research Organization (ACRO) experts say.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.